| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |